Schizophrenia is a significant psychopathology that is marked by symptoms such as hallucinations, delusions, disorganized thinking, and emotional flatness. The term "schizophrenia" was first used in the 1920s. Symptoms: Positive symptoms: These are symptoms that are present in addition to normal experience and can include hallucinations (hearing or seeing things that are not there), delusions (false beliefs), and disordered thinking, such as jumping from one topic to another. Negative symptoms: Negative symptoms are symptoms that are present in addition to normal experience and can include agitation, depression, and anxiety. Negative symptoms are those that are associated with a decline in normal functioning and include emotional flatness, a lack of drive, and social retreat, among other things. Pharmacological treatments: antipsychotic medicines are the therapy for schizophrenia that is used the most often nowadays. These drugs function by blocking dopamine receptors in the brain, which results in a reduction in the excessive activity of dopamine, which is considered to contribute to the positive symptoms of schizophrenia. The typical antipsychotics and the atypical antipsychotics are the two most frequent categories of antipsychotic drugs. Examples of typical antipsychotics are chlorpromazine and haloperidol (such as clozapine, risperidone, and olanzapine) Particular kinds of neurotransmitters and hormones, as well as receptors: Dopamine is a neurotransmitter that is believed to have a role in the positive symptoms of schizophrenia, such as hallucinations and delusions. These symptoms are considered to be caused by schizophrenia. Antipsychotic drugs work by inhibiting the excessive activity of dopamine in the brain's dopamine receptors, which is considered to be a contributing factor in the development of these symptoms. It is a neurotransmitter known as glutamate, and it is suspected to have a role in the negative symptoms of schizophrenia, such as emotional flatness and a lack of desire. According to findings from recent studies, several atypical antipsychotic drugs may be effective because they target the glutamate system in the brain. Heritability and/or genetics: Schizophrenia is a complicated condition that may have a number of different origins, and it is believed that it is impacted by both hereditary elements and environmental variables. According to the findings of research on twins, the heritability of schizophrenia is around 80%. Recent studies have uncovered a number of genes that may contribute to an individual's likelihood of developing schizophrenia. Among these genes are those that are associated with the dopamine and glutamate neurotransmitter systems. Neuroimaging and other facts on the many processes and differences in the brain: Studies using structural brain imaging have found that people who have schizophrenia have abnormalities in the structure of their brains. These abnormalities include a smaller brain volume and less gray matter in certain regions of the brain, such as the hippocampus, the prefrontal cortex, and the temporal lobes. The prefrontal cortex, the temporal lobes, and the hippocampus are all regions of the brain that are involved in cognitive processes such as attention, memory, and emotion. Functional neuroimaging studies have found that individuals with schizophrenia have abnormal brain activity in these regions of the brain. Research has shown that persons with schizophrenia have aberrant connection between various parts of the brain, which may be a factor in the symptoms of the condition. Schizophrenia is a complicated mental illness that may manifest itself in a variety of ways, including but not limited to hallucinations, delusions, disorganized thinking, and emotional flatness. It is believed that both genetic and environmental variables play a role in its development, and research has uncovered a number of genes that may enhance one's likelihood of being affected by the illness. The most common method for treating schizophrenia is using antipsychotic medication, which achieves its therapeutic effect via the inhibition of dopamine receptors in the brain. Imaging studies of the brain have shown that people who suffer from schizophrenia have abnormal brain structure and activity in certain regions of the brain, as well as abnormal connectivity between different regions of the brain. This may be a factor in the symptoms that are associated with the disorder. 